Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ADHD
Pharma
Pfizer, Tris settle ADHD drug claims with $41.5M in Texas
Pfizer and manufacturer Tris Pharma were accused in 2023 of providing ADHD med Quillivant on Texas' Medicaid despite failed quality control tests.
Zoey Becker
Nov 20, 2025 11:35am
Aurobindo acquires US drugmaker Lannett for $250M
Aug 7, 2025 9:35am
Supernus casts Busy Philipps in Qelbree push for women with ADHD
May 21, 2025 10:52am
Axsome will begin trial this year in MDD with daytime sleepiness
Apr 1, 2025 4:40pm
Axsome's Sunosi scores in phase 3 ADHD trial
Mar 25, 2025 11:46am
DEA raises production quota on Takeda's Vyvanse and its generics
Sep 4, 2024 3:24pm
